BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29630020)

  • 21. Impact of Primary Care Physician Interaction on Longitudinal Adherence to Screening Mammography Across Different Racial/Ethnic Groups.
    Flores EJ; López D; Miles RC; Glover M; Lehman CD; Harvey HB; Narayan AK
    J Am Coll Radiol; 2019 Jul; 16(7):908-914. PubMed ID: 30737162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insurance status, comorbidity level, and survival among colorectal cancer patients age 18 to 64 years in the National Cancer Data Base from 2003 to 2005.
    Robbins AS; Pavluck AL; Fedewa SA; Chen AY; Ward EM
    J Clin Oncol; 2009 Aug; 27(22):3627-33. PubMed ID: 19470927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer.
    Swegal WC; Herbert RJ; Eisele DW; Chang J; Bristow RE; Gourin CG
    Laryngoscope; 2020 Mar; 130(3):672-678. PubMed ID: 31169916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical Cancer Screening Guideline Adherence Before and After Guideline Changes in Pennsylvania Medicaid.
    Parekh N; Donohue JM; Men A; Corbelli J; Jarlenski M
    Obstet Gynecol; 2017 Jan; 129(1):66-75. PubMed ID: 27926644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment patterns and survival among low-income medicaid patients with head and neck cancer.
    Subramanian S; Chen A
    JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):489-95. PubMed ID: 23598992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.
    Nadpara P; Madhavan SS; Tworek C
    Cancer Epidemiol; 2015 Dec; 39(6):1136-44. PubMed ID: 26138902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women.
    Doll KM; Meng K; Gehrig PA; Brewster WR; Meyer AM
    Am J Obstet Gynecol; 2016 Oct; 215(4):447.e1-447.e13. PubMed ID: 27130238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.
    Hodeib M; Chang J; Liu F; Ziogas A; Dilley S; Randall LM; Anton-Culver H; Bristow RE
    Gynecol Oncol; 2015 Jul; 138(1):121-7. PubMed ID: 25913132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer.
    Hamilton AS; Fleming ST; Wang D; Goodman M; Wu XC; Owen JB; Lo M; Ho A; Anderson RT; Thompson T
    Am J Clin Oncol; 2016 Feb; 39(1):55-63. PubMed ID: 24390274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
    Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
    Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparities in pancreas cancer care.
    Abraham A; Al-Refaie WB; Parsons HM; Dudeja V; Vickers SM; Habermann EB
    Ann Surg Oncol; 2013 Jun; 20(6):2078-87. PubMed ID: 23579872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma.
    Voss RK; Chiang YJ; Torres KE; Guadagnolo BA; Mann GN; Feig BW; Cormier JN; Roland CL
    Ann Surg Oncol; 2017 Oct; 24(11):3271-3278. PubMed ID: 28741122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparities Among Cervical Cancer Patients Receiving Brachytherapy.
    Bruce SF; Joshi TV; Chervoneva I; Yi M; Chatterjee-Paer S; Burton ER; Edelson MI; Sorosky JI; Shahin MS
    Obstet Gynecol; 2019 Sep; 134(3):559-569. PubMed ID: 31403593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of Geographic Location to Disparities in Ovarian Cancer Treatment.
    Villanueva C; Chang J; Bartell SM; Ziogas A; Bristow R; Vieira VM
    J Natl Compr Canc Netw; 2019 Nov; 17(11):1318-1329. PubMed ID: 31693984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of mediators of racial disparities in cervical cancer survival in the United States.
    Sheppard CS; El-Zein M; Ramanakumar AV; Ferenczy A; Franco EL
    Int J Cancer; 2016 Jun; 138(11):2622-30. PubMed ID: 26756569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients.
    Wollschläger D; Meng X; Wöckel A; Janni W; Kreienberg R; Blettner M; Schwentner L
    Breast J; 2018 Mar; 24(2):120-127. PubMed ID: 28685896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.
    Joslin CE; Brewer KC; Davis FG; Hoskins K; Peterson CE; Pauls HA
    Gynecol Oncol; 2014 Nov; 135(2):285-91. PubMed ID: 25173584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer sociodemographic and diagnostic disparities in Florida: a population-based study (1981-2013) by stage at presentation.
    Gauri A; Messiah SE; Bouzoubaa LA; Moore KJ; Koru-Sengul T
    Ethn Health; 2020 Oct; 25(7):995-1003. PubMed ID: 29732918
    [No Abstract]   [Full Text] [Related]  

  • 39. Racial disparities in the treatment of advanced epithelial ovarian cancer.
    Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
    Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.
    Galvan-Turner VB; Chang J; Ziogas A; Bristow RE
    Gynecol Oncol; 2015 Dec; 139(3):495-9. PubMed ID: 26387962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.